This inventor holds 6 USPTO granted patents and 36 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: The University of Chicago, Northwestern University, Ikaika Therapeutics, LLC. Active years: 2016-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 966 
3 out of 2,220 
1 out of 1 Years Active: 2016-2026
Title: Innovations by Elizabeth McNally in Muscular Dystrophy Treatment
Introduction
Elizabeth McNally is a prominent inventor based in Oak Park, IL (US). She has made significant contributions to the field of genetic research, particularly in the treatment of muscular dystrophy. With a total of 6 patents to her name, her work focuses on innovative methods to address genetic disorders.
Latest Patents
One of her latest patents is titled "Compositions and methods for correcting limb girdle muscular dystrophy type 2C using exon skipping." This invention is directed towards one or more antisense polynucleotides and their application in pharmaceutical compositions. The strategy aims to induce exon skipping in the γ-sarcoglycan gene for patients suffering from Limb-Girdle Muscular Dystrophy-2C (LGM-D2C) or those at risk of developing this condition. The invention also outlines methods for preventing or treating muscular dystrophy, such as LGMD2C, through exon skipping in the gamma sarcoglycan gene using antisense polynucleotides. In some aspects, the invention provides an isolated antisense oligonucleotide that specifically hybridizes to an exon target region of a γ-sarcoglycan RNA. Additionally, it includes a method for inducing exon-skipping of a gamma sarcoglycan RNA by delivering an antisense oligonucleotide or a composition to a cell.
Career Highlights
Throughout her career, Elizabeth McNally has worked with esteemed institutions such as the University of Chicago and Northwestern University. Her research has been pivotal in advancing the understanding and treatment of muscular dystrophies.
Collaborations
Some of her notable coworkers include Eugene Wyatt and Ahlke Heydemann. Their collaborative efforts have contributed to the success of her research and innovations.
Conclusion
Elizabeth McNally's work in the field of muscular dystrophy treatment showcases her dedication to advancing medical science through innovative solutions. Her contributions continue to inspire future research and development in genetic therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile